Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Oncotarget|October 14, 2016
Individual patient oesophageal cancer 3D models for tailored treatmentJohn H Saunders, David Onion, Pamela Collier, et al.
Antioxidants & Redox Signaling|August 17, 2012
Are DNA repair factors promising biomarkers for personalized therapy in gastric cancer?Tarek Abdel-Fatah, Arvind Arora, Ipek Gorguc, et al.
British Journal of Nursing (Mark Allen Publishing)|March 18, 2026
The Integrated Foregut Clinical History: enabling nurse-led, joined-up initiation of suspected-cancer pathwaysRobyn Parkes, Clare Probert, Stacey Baker, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 17, 2006
Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind studyDileep N Lobo, Robert N Williams, Neil T Welch, et al.
BMJ Open|September 15, 2019
Winter cancellations of elective surgical procedures in the UK: a questionnaire survey of patients on the economic and psychological impactPhilip J J Herrod, Alfred Adiamah, Hannah Boyd-Carson, et al.
International Journal of Cancer|May 18, 2010
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialMarkus M Heiss, Pawel Murawa, Piotr Koralewski, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Cell Reports. Medicine|June 22, 2022
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblastsBenjamin P Sharpe, Annette Hayden, Antigoni Manousopoulou, et al.
JAMA Surgery|June 23, 2021
Risk Prediction Model of 90-Day Mortality After Esophagectomy for CancerXavier Benoit D'Journo, David Boulate, Alex Fourdrain, et al.
Pageof 4